000			01873 a2200541 4500
005			20250515050141.0
264		0	_c20071107
008			200711s 0 0 eng d
022			_a1432-0584
024	7		_a10.1007/s00277-006-0202-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aDungarwalla, M
245	0	0	_aLack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. _h[electronic resource]
260			_bAnnals of hematology _cMar 2007
300			_a191-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnemia, Hemolytic, Autoimmune _xdrug therapy
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aBronchiectasis _xchemically induced
650	0	4	_aDrug Administration Routes
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeutropenia _xdrug therapy
650	0	4	_aPilot Projects
650	0	4	_aPneumonia, Pneumocystis _xchemically induced
650	0	4	_aPurpura, Thrombocytopenic _xdrug therapy
650	0	4	_aRed-Cell Aplasia, Pure _xdrug therapy
650	0	4	_aRituximab
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aMarsh, J C W
700	1		_aTooze, J A
700	1		_aLucas, G
700	1		_aOuwehand, W
700	1		_aPettengell, R
700	1		_aDearden, C E
700	1		_aGordon Smith, E C
700	1		_aElebute, M O
773	0		_tAnnals of hematology _gvol. 86 _gno. 3 _gp. 191-7
856	4	0	_uhttps://doi.org/10.1007/s00277-006-0202-5 _zAvailable from publisher's website
999			_c16694394 _d16694394